If You Invested in Donaldson Inc (DCI)

Donaldson Company, Inc. (NYSE: DCI) is a global manufacturer focused on technology-led filtration products and solutions. According to the company, it serves a broad range of industries and advanced markets and addresses complex filtration challenges through three primary segments: Mobile Solutions, Industrial Solutions and Life Sciences. Founded in 1915 and traded on the New York Stock Exchange, Donaldson has grown into a filtration specialist with operations on six continents and a diversified base of customers that includes small businesses, research and development organizations and large original equipment manufacturer (OEM) brands.

Donaldson describes itself as a global leader in filtration, emphasizing technology-driven products and solutions. Its business is organized to focus on specific applications and end markets. The Mobile Solutions segment is associated with off-road, on-road and aftermarket applications. Company disclosures highlight off-road and on-road equipment, as well as replacement parts sold through both OEM and independent channels. The Industrial Solutions segment includes Industrial Filtration Solutions and Aerospace and Defense, reflecting filtration needs in industrial environments, power generation, dust collection and specialized aerospace and defense applications. The Life Sciences segment is oriented toward advanced markets such as food and beverage and disk drive applications, and the company has expanded this area through acquisitions such as Isolere Bio by Donaldson.

In its public materials, Donaldson notes that it operates from over 140–150 locations on six continents, with a workforce it describes as diverse and skilled. These teams work with customers ranging from small business owners to some of the world’s largest OEM brands. The company’s stated focus is on solving complex filtration challenges, which can include air and liquid filtration and related systems. Earlier descriptions also reference filtration systems and replacement parts, such as air filtration systems, liquid filtration systems and dust, fume and mist collectors, underscoring the breadth of its filtration-related offerings.

Donaldson’s segment structure is central to understanding its business model. In Mobile Solutions, the company reports activity in off-road, on-road and aftermarket categories. Off-road includes equipment used in areas such as construction and agriculture, while on-road reflects filtration products tied to global truck production and related vehicle fleets. Aftermarket sales are highlighted by the company as an important driver, with references to market share gains in independent channels and solid demand in OEM channels. Management has also described its aftermarket approach using a “razor-to-sell-razorblades” model, emphasizing the importance of ongoing replacement part sales following initial equipment placement.

Within Industrial Solutions, Donaldson reports Industrial Filtration Solutions and Aerospace and Defense as key businesses. Industrial Filtration Solutions includes new systems and replacement parts for dust collection, as well as filtration for power generation and industrial hydraulics. Company updates have pointed to strength in new power generation systems and dust collection replacement parts, while also noting variability in industrial hydraulics and defense-related volumes. The Aerospace and Defense business reflects filtration needs in specialized and often cyclical markets, where changes in defense spending and project timing can influence segment performance.

The Life Sciences segment reflects Donaldson’s effort to participate in advanced and specialized filtration markets. Public disclosures highlight strong new equipment and replacement part sales in food and beverage and disk drive applications. In addition, the company has expanded its capabilities through the acquisition of Isolere Bio, which operates as Isolere Bio by Donaldson. Isolere Bio is described as an innovator in biopharmaceutical purification technologies, focusing on streamlined solutions for complex biologics and bioprocessing. This acquisition supports Donaldson’s stated life sciences vision of building bioprocessing solutions that can reduce costs and increase speed of development for essential reagents and medicines.

Donaldson’s financial communications emphasize a combination of sales growth, margin management and cost optimization. Recent results have referenced record sales and earnings, with growth in replacement parts and new equipment across multiple segments. The company has highlighted pricing benefits, favorable foreign currency translation and volume growth as contributors to sales increases, along with efforts to optimize its cost structure and footprint. Management commentary has also stressed operating expense discipline, leverage on higher sales and initiatives aimed at improving structural efficiency.

Capital allocation is another recurring theme in Donaldson’s disclosures. The company regularly discusses dividends and share repurchases, and notes that it has paid a cash dividend every quarter for many decades. Donaldson is identified as a member of the S&P High-Yield Dividend Aristocrats Index, and calendar year 2025 is cited as marking the 30th consecutive year of annual dividend increases. The company also reports returning capital to shareholders through repurchases of its common stock, while investing in property, plant and equipment, acquisitions and equity investments to support long-term growth.

Governance and shareholder engagement are addressed through proxy and meeting materials. Donaldson holds an annual meeting of stockholders and files a definitive proxy statement (DEF 14A) that outlines proposals such as the election of directors, an advisory vote on executive compensation and ratification of the independent registered public accounting firm. The company describes its corporate governance framework, including board oversight, committee responsibilities, director selection processes and policies related to ethics, risk oversight and stockholder communications.

Donaldson’s shares trade on the New York Stock Exchange under the ticker symbol DCI. The company is included in dividend-focused indices and communicates regularly with investors through earnings releases, conference presentations and webcasts. Its public statements emphasize a long operating history in filtration, a multi-segment structure spanning mobile, industrial and life sciences applications, and a strategy that combines technology-led products with recurring replacement part demand.

Business Segments and End Markets

Mobile Solutions focuses on filtration for mobile equipment and vehicles. Company disclosures reference off-road markets such as construction and agriculture, on-road markets tied to global truck production and an aftermarket business serving both OEM and independent channels. Sales performance in this segment is influenced by equipment production levels, regional demand and vehicle utilization, as well as the ongoing need for replacement parts.

Industrial Solutions addresses filtration needs in industrial environments and specialized applications. Industrial Filtration Solutions includes dust collection systems and replacement parts, power generation filtration and industrial hydraulics. Aerospace and Defense provides filtration solutions for aircraft and defense-related platforms. Segment performance can reflect project timing, capital spending cycles and defense demand.

Life Sciences extends Donaldson’s filtration expertise into advanced markets. The company highlights food and beverage and disk drive applications, and through Isolere Bio by Donaldson, participates in biopharmaceutical purification technologies. Isolere Bio’s focus on bioprocessing and complex biologics aligns with Donaldson’s stated goal of building life sciences capabilities that support the development and commercialization of essential therapies.

Investor Considerations

For investors and analysts, Donaldson’s disclosures provide insight into segment-level trends, margin performance and capital allocation priorities. Earnings releases and related materials discuss factors such as pricing, currency effects, volume changes, tariff impacts, cost optimization initiatives and investment in research and development. The company also communicates guidance ranges for sales, operating margin and earnings, along with expectations for capital expenditures, tax rates and share repurchases.

According to its public statements, Donaldson’s long history, global footprint and focus on filtration technologies underpin its role in serving a broad set of industrial, mobile and life sciences markets. Its combination of original equipment and aftermarket business, along with a growing presence in advanced applications, frames the company’s positioning within the filtration space.